EMA panel recommends Merck, Pfizer's diabetes drug

(Reuters) - A European Medicines Agency (EMA) panel on Friday recommended granting marketing approval to a diabetes drug developed by Merck & Co (MRK.N) and Pfizer Inc (PFE.N). The recommendation by EMA's ...